One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Advances in Lipid Science: Mechanisms, Targets, and Clinical Insights
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies
Angiopoietin-Like Protein 3 Inhibition: A Key to Silencing Residual Lipid Risk?
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia: A Phase 2 Study
Beyond LDL: Targeting ANGPTL3 to Reduce Residual Cardiovascular Risk
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia
Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and Cardiovascular Implications
Effects of Tirzepatide in Type 2 Diabetes: Individual Variation and Relationship to Cardiometabolic Outcomes
Individual Variability in the Cardiometabolic Response to Tirzepatide: Moving Beyond the Average
Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition: Medical Life-Trajectories in the Post-2010 Era
Amara Yad Image: Left Anterior Oblique View of the Heart Showing the Pulmonary Trunk
